Literature DB >> 21088584

Response to treatment in bipolar disorder.

Cristiana Cruceanu1, Martin Alda, Guy Rouleau, Gustavo Turecki.   

Abstract

PURPOSE OF REVIEW: Bipolar disorder is a complex psychiatric condition that has been shown to carry a great degree of genetic loading. This review addresses current research in the genetics of treatment response in bipolar disorder, with a focus on findings that have shaped our understanding of the changing direction of this field in light of recent technological advancements. RECENT
FINDINGS: The recent publications in bipolar disorder treatment response have helped consolidate or improve upon knowledge of susceptibility loci and genes in the field. There seems to be an increasing trend toward functionally assessing the role played by putative candidate genes and molecular factors modulating expression in bipolar disorder, as well as a movement toward more global, pathway and genome-wide-oriented research.
SUMMARY: Genetic and molecular research to date in bipolar disorder treatment response has not completely answered all the lingering questions in the field, but has contributed to the development of a more patient-based understanding of treatment. In order to apply these findings at a clinical level, more comprehensive treatment response studies are imperative, combining recent advances in high-throughput genomics with functional molecular research.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21088584      PMCID: PMC3478324          DOI: 10.1097/YCO.0b013e328341352c

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  47 in total

Review 1.  Genetics of bipolar disorder: successful start to a long journey.

Authors:  Nick Craddock; Pamela Sklar
Journal:  Trends Genet       Date:  2009-01-12       Impact factor: 11.639

2.  Therapeutic implications of down-regulation of cyclophilin D in bipolar disorder.

Authors:  Mie Kubota; Takaoki Kasahara; Kazuya Iwamoto; Atsuko Komori; Mizuho Ishiwata; Taeko Miyauchi; Tadafumi Kato
Journal:  Int J Neuropsychopharmacol       Date:  2010-04-15       Impact factor: 5.176

3.  MicroRNA-134 plasma levels before and after treatment for bipolar mania.

Authors:  Han Rong; Tie Bang Liu; Kong Jun Yang; Hai Chen Yang; Dong Hui Wu; Chun Pin Liao; Fei Hong; He Zen Yang; Feng Wan; Xiao Ying Ye; Dan Xu; Xuan Zhang; Chang An Chao; Qi Jie Shen
Journal:  J Psychiatr Res       Date:  2010-05-23       Impact factor: 4.791

4.  Lithium responsive bipolar disorder, unilineality, and chromosome 18: A linkage study.

Authors:  G Turecki; P Grof; P Cavazzoni; A Duffy; E Grof; R Martin; R Joober; G A Rouleau; M Alda
Journal:  Am J Med Genet       Date:  1999-08-20

5.  Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene.

Authors:  J K Rybakowski; A Suwalska; M Skibinska; A Szczepankiewicz; A Leszczynska-Rodziewicz; A Permoda; P M Czerski; J Hauser
Journal:  Pharmacopsychiatry       Date:  2005-07       Impact factor: 5.788

6.  A genomewide association study of response to lithium for prevention of recurrence in bipolar disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Manuel A R Ferreira; Andrew McQuillin; Nick Bass; Jacob Lawrence; Gary S Sachs; Vishwajit Nimgaonkar; Edward M Scolnick; Hugh Gurling; Pamela Sklar; Shaun Purcell
Journal:  Am J Psychiatry       Date:  2009-05-15       Impact factor: 18.112

7.  Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers.

Authors:  Rulun Zhou; Peixiong Yuan; Yun Wang; Joshua G Hunsberger; Abdel Elkahloun; Yanling Wei; Patricia Damschroder-Williams; Jing Du; Guang Chen; Husseini K Manji
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

Review 8.  Lithium response across generations.

Authors:  P Grof; A Duffy; M Alda; T Hajek
Journal:  Acta Psychiatr Scand       Date:  2009-11       Impact factor: 6.392

9.  Examination of IMPA1 and IMPA2 genes in manic-depressive patients: association between IMPA2 promoter polymorphisms and bipolar disorder.

Authors:  G Sjøholt; R P Ebstein; R T Lie; J Ø Berle; J Mallet; J F Deleuze; D F Levinson; C Laurent; M Mujahed; I Bannoura; I Murad; A Molven; V M Steen
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

10.  FYN kinase gene: another glutamatergic gene associated with bipolar disorder?

Authors:  Aleksandra Szczepankiewicz; Janusz K Rybakowski; Maria Skibinska; Monika Dmitrzak-Weglarz; Anna Leszczynska-Rodziewicz; Monika Wilkosc; Joanna Hauser
Journal:  Neuropsychobiology       Date:  2009-05-20       Impact factor: 2.328

View more
  9 in total

Review 1.  Predictive animal models of mania: hits, misses and future directions.

Authors:  Jared W Young; Brook L Henry; Mark A Geyer
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

2.  International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic).

Authors:  Takahiro Soda; Declan M McLoughlin; Scott R Clark; Leif Oltedal; Ute Kessler; Jan Haavik; Chad Bousman; Daniel J Smith; Miquel Bioque; Caitlin C Clements; Colleen Loo; Fidel Vila-Rodriguez; Alessandra Minelli; Brian J Mickey; Roumen Milev; Anna R Docherty; Julie Langan Martin; Eric D Achtyes; Volker Arolt; Ronny Redlich; Udo Dannlowski; Narcis Cardoner; Emily Clare; Nick Craddock; Arianna Di Florio; Monika Dmitrzak-Weglarz; Liz Forty; Katherine Gordon-Smith; Mustafa Husain; Wendy M Ingram; Lisa Jones; Ian Jones; Mario Juruena; George Kirov; Mikael Landén; Daniel J Müller; Axel Nordensköld; Erik Pålsson; Meethu Paul; Agnieszka Permoda; Bartlomiej Pliszka; Jamie Rea; Klaus O Schubert; Joshua A Sonnen; Virginia Soria; Will Stageman; Akihiro Takamiya; Mikel Urretavizacaya; Stuart Watson; Maxim Zavorotny; Allan H Young; Eduard Vieta; Janusz K Rybakowski; Massimo Gennarelli; Peter P Zandi; Patrick F Sullivan; Bernhard T Baune
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-12-04       Impact factor: 5.270

Review 3.  Molecular actions and clinical pharmacogenetics of lithium therapy.

Authors:  Adem Can; Thomas G Schulze; Todd D Gould
Journal:  Pharmacol Biochem Behav       Date:  2014-02-15       Impact factor: 3.533

4.  CRY1 Variations Impacts on the Depressive Relapse Rate in a Sample of Bipolar Patients.

Authors:  Antonio Drago; Barbara Monti; Diana De Ronchi; Alessandro Serretti
Journal:  Psychiatry Investig       Date:  2015-01-12       Impact factor: 2.505

Review 5.  The Genetics of Response to and Side Effects of Lithium Treatment in Bipolar Disorder: Future Research Perspectives.

Authors:  Fanny Senner; Mojtaba Oraki Kohshour; Safa Abdalla; Sergi Papiol; Thomas G Schulze
Journal:  Front Pharmacol       Date:  2021-03-25       Impact factor: 5.810

6.  Circular RNA circCCNT2 is upregulated in the anterior cingulate cortex of individuals with bipolar disorder.

Authors:  Rixing Lin; Juan Pablo Lopez; Cristiana Cruceanu; Caroline Pierotti; Laura M Fiori; Alessio Squassina; Caterina Chillotti; Christoph Dieterich; Nikolaos Mellios; Gustavo Turecki
Journal:  Transl Psychiatry       Date:  2021-12-10       Impact factor: 6.222

Review 7.  Coding and noncoding gene expression biomarkers in mood disorders and schizophrenia.

Authors:  Firoza Mamdani; Maureen V Martin; Todd Lencz; Brandi Rollins; Delbert G Robinson; Emily A Moon; Anil K Malhotra; Marquis P Vawter
Journal:  Dis Markers       Date:  2013-07-21       Impact factor: 3.434

Review 8.  Omics-Based Biomarkers: Application of Metabolomics in Neuropsychiatric Disorders.

Authors:  Sumit Sethi; Elisa Brietzke
Journal:  Int J Neuropsychopharmacol       Date:  2015-10-09       Impact factor: 5.176

9.  Genes Encoding GABA-β and HT1D Receptors in Bipolar I (Manic Phase) Patients.

Authors:  Mohammadreza Moradi; Massoud Saidijam; Reza Yadegarazari; Leila Jahangard; Maryam Seifi; Nasrin Matinnia; Ali Ghaleiha
Journal:  Basic Clin Neurosci       Date:  2018 Mar-Apr
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.